
Erythema Multiforme
Definition
Self-limiting, immune-mediated condition affecting mucocutaneous surfaces. Presents with target-like lesions and can be isolated, recurrent, or persistent.
Primarily affects young adults (~1%).

Aetiology & Causes
Idiopathic (common)
Infections:
Herpes simplex virus (HSV) (most common)
Mycoplasma pneumoniae (next most common), COVID-19, CMV, EBV
Drugs: Sulphonamides (e.g. co-trimoxazole), penicillins, anticonvulsants
Systemic disease: SLE, Hodgkin’s lymphoma
Vaccinations
Clinical Features
Skin Lesions
Symmetrical rash, mainly on extensor surfaces
Target lesions (hallmark sign) with three zones:
Dusky centre (epidermal necrosis)
Pale oedematous ring
Peripheral erythematous rim
May be painful, itchy, or swollen
Mucosal Involvement
Blisters → shallow ulcers covered by a white membrane
Affects oral mucosa, causing pain with eating/swallowing
Diagnosis
Clinical diagnosis based on history and examination
If doubt: Consider keratitis, conjunctival screening, uveitis (risk of visual impairment)
Differential Diagnosis
SJS/TEN (key distinction):
More severe mucosal damage, skin peeling, systemic illness
Others:
Urticaria, viral exanthem, fixed drug eruption
Bullous pemphigoid, paraneoplastic pemphigus
Polymorphous light eruption, Rowell syndrome (SLE-related)
Management
Usually self-limiting, no specific treatment needed
Symptomatic care:
Itching: Antihistamines, topical steroids, cool compresses
Pain: Local anaesthetic gels, mouth rinses
Eye involvement: Urgent ophthalmology referral
Recurrent/severe cases:
Oral antivirals (e.g. aciclovir) if HSV-related
Antibiotics if bacterial trigger (e.g. Mycoplasma pneumoniae)
Prognosis
Minor cases resolve in 2–3 weeks without scarring
Erythema multiforme major may take up to 6 weeks
Rare progression to SJS/TEN, but eye involvement may cause long-term complications (e.g. vision loss)
Bookmark Failed!
Bookmark Saved!